Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease

NCT00857649 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

369

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Memantine
DRUG: Placebo

Sponsor

H. Lundbeck A/S